Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 167, Suchdauer: 0.88s

12 3 4 5 6 7 weiter »

1
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial

von Wermke, Martin ; Araujo, Dejka M. ; Chatterjee, Manik ; et al.

Nature Medicine. 31(7):2365-2374
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

2
HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry

von Michael Weller ; Roland Martin ; Holger Moch ; et al.

Journal for ImmunoTherapy of Cancer, Vol 13, Iss 8 (2025)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

3
Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial

von Wermke, Martin ; Araujo, Dejka M. ; Chatterjee, Manik ; et al.

Nature Medicine. 31(7):2453-2453
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

4
372 TCR-engineered T cells exhibit enhanced persistence and serial killing ability when armored with membrane-bound IL-15

von Gunesch, Justin T ; Hossain, Mohammad B ; Secker-Grob, Kathy-Ann ; et al.

Regular and Young Investigator Award Abstracts ; page A428-A428
- View full text via BASE
Merkliste

5
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors

von Ignacio I Wistuba ; Mamta Kalra ; Linus Backert ; et al.

Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

6
Pitfalls in HLA Ligandomics—How to Catch a Li(e)gand

von Fritsche, Jens ; Kowalewski, Daniel J. ; Backert, Linus ; et al.

In Molecular & Cellular Proteomics 2021 20
- View full text via DOI
Merkliste

7
713 The PRAME opportunity – high peptide copy numbers, homogenous expression and high prevalence to address a broad patient population across different solid cancers with TCR-based therapeutics

von Britten, Cedrik ; Araujo, Dejka ; Backert, Linus ; et al.

Regular and Young Investigator Award Abstracts ; page A746-A746
- View full text via BASE
Merkliste

8
AureoWiki ̵ The repository of the Staphylococcus aureus research and annotation community

von Fuchs, Stephan ; Mehlan, Henry ; Bernhardt, Jörg ; et al.

In International Journal of Medical Microbiology August 2018 308(6):558-568
- View full text via DOI
Merkliste

9
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

von Anna Reustle ; Moreno Di Marco ; Carolin Meyerhoff ; et al.

Genome Medicine, Vol 12, Iss 1, Pp 1-24 (2020)

Schlagworte: ccRCC; Renal cell carcinoma; Ligandomics; HLA peptidome; Immunotherapy; Peptide vaccine; Medicine; Genetics; QH426-470
- View full text via DOI
Merkliste

10
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

von Hans-Georg Rammensee ; Karl-Heinz Wiesmüller ; P. Anoop Chandran ; et al.

Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-18 (2019)

Schlagworte: Adjuvant; Lipopeptide; TLR1/2 ligand; Immunotherapy; Vaccines; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

11
HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry

von Bichmann, Leon ; Kowalewski, Daniel Johannes ; Freudenmann, Lena Katharina ; et al.

Schlagworte: 004
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

12
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

von Alberer, Martin ; Gnad-Vogt, Ulrike ; Hong, Henoch Sangjoon ; et al.

In The Lancet 23-29 September 2017 390(10101):1511-1520
- View full text via DOI
Merkliste

13
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

von Jian Wang ; Michael Weller ; Roland Martin ; et al.

Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

14
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

von Marcu, Ana ; Bichmann, Leon ; Kuchenbecker, Leon ; et al.

Marcu, Ana; Bichmann, Leon; Kuchenbecker, Leon; Kowalewski, Daniel Johannes; Freudenmann, Lena Katharina; Backert, Linus; Mühlenbruch, Lena; Szolek, András; Lübke, Maren; Wagner, Philipp; Engler, Tobias; Matovina, Sabine; Wang, Jian; Hauri-Hohl, Mathias; Martin, Roland; Kapolou, Konstantina; Walz, Juliane Sarah; Velz, Julia; Moch, Holger; Regli, Luca; Silginer, Manuela; Weller, Michael; Löffler, Markus W; Erhard, Florian; Schlosser, Andreas; Kohlbacher, Oliver; Stevanović, Stefan; Rammensee, Hans-Georg; Neidert, Marian Christoph (2021). HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 9(4):18.

Schlagworte: Clinic for Neurology; Institute of Pathology and Molecular Pathology; Clinic for Neurosurgery; Medical Clinic; Clinic for Surgery; 610 Medicine & health
- View full text via BASE
Merkliste

15
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy

von Neidert, Marian Christoph ; Kowalewski, Daniel Johannes ; Silginer, Manuela ; et al.

Acta Neuropathologica: Pathology and Mechanisms of Neurological Disease. 135(6):923-938
- Zum Volltext (via ReDI)
Merkliste

16
The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

von Walz, Simon ; Stickel, Juliane S. ; Kowalewski, Daniel Johannes ; et al.

In Blood 3 September 2015 126(10):1203-1213
- View full text via DOI
Merkliste

17
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation

von Haen ; Groh, Christiane ; Schumm, Michael ; et al.

Annals of Hematology. :1-11
- Zum Volltext (via ReDI)
Merkliste

18
HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

von Annika Nelde ; Daniel J. Kowalewski ; Linus Backert ; et al.

OncoImmunology, Vol 7, Iss 4 (2018)

Schlagworte: chronic lymphocytic leukemia; hla; lenalidomide; mass spectrometry; t-cell-based immunotherapy; Immunologic diseases. Allergy; RC581-607; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

19
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

20
A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and 'pan-leukemia' antigens

von Backert, Linus ; Kowalewski, Daniel Johannes ; Kanz, Lothar ; et al.

OncoTarget : open access impact journal 8(27), 43915-43924 (2017). doi:10.18632/oncotarget.14918

Schlagworte: DE
- View full text via BASE
Merkliste

21
Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices

von Di Marco, Moreno ; Schuster, Heiko ; Backert, Linus ; et al.

The Journal of Immunology ; volume 199, issue 8, page 2639-2651 ; ISSN 0022-1767 1550-6606
- View full text via BASE
Merkliste

22
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

von Lundqvist, Andreas ; van Hoef, Vincent ; Zhang, Xiaonan ; et al.
- View full text via BASE
Merkliste

23
Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy.

von Sharon M Barth ; Christian M Schreitmüller ; Franziska Proehl ; et al.

PLoS ONE, Vol 11, Iss 11, p e0167017 (2016)

Schlagworte: Medicine; Science
- View full text via DOI
Merkliste

24
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy

von Hong, Henoch S. ; Koch, Sven D. ; Scheel, Birgit ; et al.

OncoImmunology ; volume 5, issue 12, page e1249560 ; ISSN 2162-402X
- View full text via BASE
Merkliste

25
Immunoinformatics and epitope prediction in the age of genomic medicine

von Backert, Linus ; Kohlbacher, Oliver ; Deutsche Forschungsgemeinschaft (SFB 685)

Genome Medicine ; volume 7, issue 1 ; ISSN 1756-994X
- View full text via BASE
Merkliste

12 3 4 5 6 7 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag